Abstract:Background: Protein A, protein G and protein L are three well-defined immunoglobulin (Ig)-binding proteins (IBPs), which show affinity for specific sites on Ig of mammalian hosts. Although the precise functions of these molecules are not fully understood, it is thought that they play an important role in pathogenicity of bacteria. The single domains of protein A, protein G and protein L were all demonstrated to have function to bind to Ig. Whether combinations of Ig-binding domains of various IBPs could exhibit useful novel binding is interesting.Results: We used a combinatorial phage library which displayed randomly-rearranged various-peptide-linked molecules of D and A domains of protein A, designated PA(D) and PA(A) respectively, B2 domain of protein G (PG) and B3 domain of protein L (PL) for affinity selection with human IgG (hIgG), human IgM (hIgM), human IgA (hIgA) and recombinant hIgG1-Fc as bait respectively. Two kinds of novel combinatorial molecules with characteristic structure of PA(A)-PG and PA(A)-PL were obtained in hIgG (hIgG1-Fc) and hIgM (hIgA) post-selection populations respectively. In addition, the linking peptides among all PA(A)-PG and PA(A)-PL structures was strongly selected, and showed interestingly divergent and convergent distribution. The phage binding assays and competitive inhibition experiments demonstrated that PA( A)PG and PA(A)-PL combinations possess comparable binding advantages with hIgG/hIgG1-Fc and hIgM/hIgA respectively.Conclusion: In this work, a combinatorial phage library displaying Ig-binding domains of protein A, protein G, or protein L joined by various random linking peptides was used to conducted evolutional selection in vitro with four kinds of Ig molecules. Two kinds of novel combinations of Ig-binding domains, PA(A)-PG and PA(A)-PL, were obtained, and demonstrate the novel Ig binding properties.

Phage-based molecular directed evolution yields multiple tandem human IgA affibodies with intramolecular binding avidity.

Construction of Phage-Displayed Random Combinatorial Library of IgA Affibodies and Its Directed in Vitro Evolution

Construction of phage-displayed random combinatorial library of IgA affibodies

Evolutional Selection of a Combinatorial Phage Library Displaying Randomly-Rearranged Various Single Domains of Immunoglobulin (Ig)-Binding Proteins (ibps) with Four Kinds of Ig Molecules

[In Vitro Evolutional Selection of a Combinatorial Phage Library Displaying Randomly-Rearranged Various Binding Domains of SpA and SpG with Four Human IgG Subclasses].

In Vitro Molecular Evolution Yields an NEIBM with a Potential Novel IgG Binding Property

Phage Display of Random Combinatorial Libraries of Ig-Binding Mono-Domains of Protein A and Protein L and Ig Affinity Screening

In Vitro Molecular Evolution of AL NEIBMs Improved Immunoglobulin (ig) Binding and Antibody Detection

Improving Antibody Affinity Through in Vitro Mutagenesis in Complementarity Determining Regions

A Fully Human Scfv Phage Display Library for Rapid Antibody Fragment Reformatting.

Affinity maturation of a human single-chain Fv by phage display

The process using a synthetic library that generates multiple diverse human single domain antibodies

i-shaped antibody engineering enables conformational tuning of biotherapeutic receptor agonists

Epivolve: A Protocol for Site-Directed Antibodies

In silico design of stable single-domain antibodies with high affinity

A Large Language Model Guides the Affinity Maturation of Variant Antibodies Generated by Combinatorial Optimization

Development and experimental validation of computational methods for human antibody affinity enhancement

Antibody light chain variable domains and their biophysically improved versions for human immunotherapy

Immunoglobulin somatic hypermutation in a defined biochemical system recapitulates affinity maturation and permits antibody optimization

A bispecific IgG format containing four independent antigen binding sites

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination